Why do some CALD patients exhibit atypically low NfL despite ongoing myelin destruction?

OPEN

The discovery of 'smoldering CALD' with low NfL contradicts the expected correlation between demyelination severity and NfL levels. This paradox suggests unknown disease mechanisms that could represent distinct therapeutic targets or require different monitoring approaches. Gap type: contradiction Source paper: Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy. (2021, Nature communications, PMID:33753741)

Priority: 0.78 Domain: neuroinflammation Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: Why do some CALD patients exhibit atypically low NfL despite ongoing myelin destruction? is a 0.78 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Why do some CALD patients exhibit atypically low NfL despite ongoing myelin destruction? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

associated with (2)

QAlbNfLNfLFunctional Decline

biomarker for (9)

NfLALSNfLNeurodegenerationNfLtreatment responseNfLBBB permeability-augmented neurodegenerationNfLaxonal degeneration
▸ Show 4 more

correlated with (1)

39249107NfL

elevated in (1)

30283395NfL

indicates (1)

NfLNeurodegeneration

reflects recovery of (1)

NfLaxonal_integrity

releases (1)

damaged neuronsNfL

was the best predictor of (1)

39249107NfL
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps